Moreover, Churi and his collaborators also highlighted targetable somatic mutations in MSH2, MLH1, ATM, BAP1, MSH6, BRCA1 and BRCA2 in 74 CCA cases [98]. Here, BRCA1 is linked to cholangiocarcinoma.